Altium Capital Management LP Applied Therapeutics Inc. Transaction History
Altium Capital Management LP
- $301 Million
- Q4 2024
A detailed history of Altium Capital Management LP transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Altium Capital Management LP holds 56,100 shares of APLT stock, worth $27,489. This represents 0.02% of its overall portfolio holdings.
Number of Shares
56,100Holding current value
$27,489% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding APLT
# of Institutions
130Shares Held
112MCall Options Held
1.1MPut Options Held
800K-
Vestal Point Capital, LP New York, NY11.5MShares$5.64 Million0.58% of portfolio
-
Vr Adviser, LLC New York, NY9.99MShares$4.9 Million1.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA9.62MShares$4.71 Million8.18% of portfolio
-
Morgan Stanley New York, NY8.82MShares$4.32 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.76MShares$4.29 Million0.05% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $23.5M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...